The Role of MEK Kinase 1 in Bcr-Abl-Induced Seｌｆ-Renewal Activity of Embryonic Stem Cells
スポンサーリンク
概要
- 論文の詳細を見る
BCR-ABL oncogene, the moecular hallmark of chronic mylogenous leukemia, arises in a promitive hematopoietic stem cell that has the capacity for both differentiation and self-renewal. Its product, Bcr-Abl protein, has been shown to sctivate signal transducers and activators of transcription 3 (STAT3) and to promote self-renewal in embryonic stem (ES)cells, even in the absencs of leukemia in hibitory factor (LIF). MEK kinase 1 (MEKK1) is a 196-kDa mitogen-activated protein kinase (MAPK) kinase kinase involoved in Bcr-Ablsignal transduction. To investigate the role of MEKK1 in bcr-Abl-induced transformation of stem cells, p210 Bcr-Abl was stably transfected into wild type (WTp210)and MEKK1-/-(MEKK1-/-p210) ES cells. Bcr-Abl enhanced MEKK1 expression in ES transfectants, as it does in other Bcr-Abl-transformed cells. In the absence of LIF, WTp210 cells showed constitutive STAT3 activation and formed rounded, compact colonies having strong alkaline phosphatase activity, a characteristic phenotype of undifferentiated ES cells. MEKK1-/-p210 cells, by contrast, showed less STAT3 activity than WTp210 cells and formed large, flattened colonies having weak alkaline phosphatase activity, a phenotype of differentiated ES cells. These results indicate that MEKK1 plays a ker role in Bcr-Abl-induced STAT3 activation and in ES cells's capacity for LIF-independent self-renewal, and may thus be involved in Bcr-Abl-mediated leukemogenesis in stem cells.
- Yamaguchi University School of Medicineの論文
著者
-
YUJIRI Toshiaki
Third Department of Internal Medicine, Yamaguchi University School of Medicine
-
Yujiri Toshiaki
Third Department Of Internal Medicine Yamaguchi University School Of Medicine
-
Tanizawa Yukio
Third Department Of Internal Medicine Yamaguchi University School Of Medicine
-
Tanaka Yoshinori
Third Department Of Internal Medicine Yamaguchi University School Of Medicine
-
Nakamura Yukinori
Third Department Of Internal Medicine Yamaguchi University School Of Medicine
-
Yujiri Toshiaki
Yamaguchi Univ. School Of Medicine Ube Jpn
-
Tanizawa Yukio
Department Of Bio-signal Analysis Yamaguchi University Graduate School Of Medicine
関連論文
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
- Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity
- OJ-298 MEKK1 is Required in Vascular Remodeling after Injury in Carotid Ligation Model(Restenosis after Angioplasty, Basic/Clinical 2 (IHD) : OJ36)(Oral Presentation (Japanese))
- Gemtuzumab Ozogamicin Therapy for Isolated Extramedullary AML Relapse after Allogeneic Hematopoietic Stem-Cell Transplantation
- Fluctuations in thrombopoietin, immature platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia
- Allogeneic Peripheral Blood Stem Cell Transplantation from Related Donors Mismatched at 2 HLA Loci in the Host-versus-Graft Direction
- A Case of Hand-Mirror Cell Variant of Multiple Myeloma
- The Role of MEK Kinase 1 in Bcr-Abl-Induced Seｌｆ-Renewal Activity of Embryonic Stem Cells
- Systemic AL amyloidosis with disseminated intravascular coagulation associated with hyperfibrinolysis
- Atypical Cholecystitis after Bone Marrow Transplantation : Gallbladder Wall Thickening due to Cyclosporine A
- Sequential Quantification of Epstein-Barr Virus DNA in a Case of Epstein-Barr Virus-Associated Hemophagocytic Syndrome
- Sustained Cytogenetic Remission Induced by Imatinib Mesylate in a Chronic Myeloid Leukemia Patient Who Had a Relapse into Lymphoid Crisis after Allogeneic Hematopoietic Stem Cell Transplantation
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Activation of the unfolded protein response in primary acute myeloid leukemia cells